Encision, Inc. income statement ECIA

Annual Quarterly

In fiscal 2025, which ended Mar 31, 2025, Encision, Inc. reported revenue of $6.6 million, down 0.5% from the year before. It recorded a net loss of $220,198. The operating loss came to $171,980, an operating margin of -2.6%. Diluted earnings per share were -$0.02. Over the twelve months ended Sep 30, 2025, revenue was $6.3 million and the net loss was $380,942. Across the 10 fiscal years shown, revenue shrank from $9.3 million in fiscal 2016 to $6.6 million in fiscal 2025, about 3.9% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2025	FY 2025 Mar 31, 2025	FY 2024 Mar 31, 2024	FY 2023 Mar 31, 2023	FY 2022 Mar 31, 2022	FY 2021 Mar 31, 2021	FY 2020 Mar 31, 2020	FY 2019 Mar 31, 2019	FY 2018 Mar 31, 2018	FY 2017 Mar 31, 2017	FY 2016 Mar 31, 2016
Revenue	6 -3.0%	7 -0.5%	7 -10.4%	7 -4.2%	8 +1.7%	8 -1.7%	8 -12.9%	9 +0.6%	9 -1.3%	9 -5.0%	9 -3.5%
Cost of revenue	3 -9.9%	3 -11.8%	3 +4.0%	3 -14.5%	4 +6.8%	4 -0.9%	4 -11.2%	4 +10.2%	4 -16.1%	4 -6.2%	5 -4.4%
Gross profit	3 +4.2%	4 +12.0%	3 -22.2%	4 +6.4%	4 -3.0%	4 -2.5%	4 -14.3%	5 -6.7%	5 +13.7%	4 -3.7%	5 -2.5%
Research and development	1 +2.8%	1 -4.6%	1 -23.8%	1 -11.1%	1 +61.2%	1 -23.9%	1 -4.0%	1 -7.4%	1 -25.3%	1 -9.9%	1 -6.9%
Selling, general and administrative	3 -6.7%	3 -2.1%	3 -10.4%	4 +1.6%	3 +2.0%	3 -0.4%	3 -16.4%	4 +8.2%	4 -5.0%	4 -1.7%	4 -11.0%
Operating expenses	4 -5.1%	4 -2.5%	4 -12.9%	4 -1.1%	4 +10.5%	4 -4.6%	4 -14.4%	5 +5.4%	5 -9.5%	5 -3.6%	5 -10.1%
Operating income	-0 +50.8%	-0 +73.2%	-1 -111.6%	-0 +49.1%	-1 -865.2%	-0 +60.6%	-0 +16.1%	-0 -147.1%	0 +157.5%	-1 +2.8%	-1 +40.2%
Interest expense	0	0	—	—	—	—	—	—	—	—	—
Other non-operating income (expense)	-0 -189.1%	-0 -139.5%	0 +802.5%	-0 -147.0%	0 -97.4%	0 +9336.0%	0 +139.5%	0 +61.8%	0 -98.0%	0 +114.9%	-0 +34.5%
Pretax income	-0 +45.0%	-0 +68.2%	-1 -113.5%	-0 -393.9%	-0 -111.2%	1 +394.9%	-0 +16.0%	-0 -170.4%	0 +146.0%	-1 +17.1%	-1 +36.3%
Income tax	0	0	—	0	0	0	0	0	0	0	0
Net income	-0 +45.0%	-0 +68.2%	-1 -113.5%	-0 -393.9%	-0 -111.2%	1 +394.9%	-0 +16.0%	-0 -170.4%	0 +146.0%	-1 +17.1%	-1
Net income to common	—	0 -68.2%	1 +113.5%	0 +593.9%	-0 -111.2%	1 +394.9%	-0 +16.0%	-0 -170.4%	0 +146.0%	-1 +17.1%	-1 +36.3%
Basic EPS	-0.03 +47.8%	-0.02 +66.7%	-0.06 -100.0%	-0.03	—	—	—	—	0.03	—	—
Diluted EPS	-0.03 +47.8%	-0.02 +66.7%	-0.06 -100.0%	-0.03	—	—	—	—	0.03	—	—
Weighted average shares, basic	12 +5.4%	12 +0.9%	12 +0.1%	12 +1.2%	12 +0.4%	12 +0.1%	12 +5.9%	11 +2.3%	11 +0.1%	11 +0.0%	11 +0.0%
Weighted average shares, diluted	12 +5.4%	12 +0.9%	12 +0.1%	12 +1.2%	12 -1.2%	12 +1.7%	12 +5.9%	11 +2.1%	11 +0.3%	11 +0.0%	11
Other measures
Depreciation and amortization	0 +4.1%	0 -4.5%	0 -1.9%	0 -23.4%	0 +27.6%	0 -35.5%	0 -24.3%	0 -10.3%	0 -9.8%	0 -29.4%	0 -16.6%
EBITDA	-0 +58.9%	-0 +83.7%	-1 -157.3%	-0 +55.2%	-0 -1862.7%	0 +247.2%	-0 -332.1%	-0 -100.7%	1 +229.2%	-0 -18.9%	-0 +51.4%
Interest coverage	-5.69x	-3.93x	—	—	—	—	—	—	—	—	—
Margins
Gross margin	52.64%	53.56%	47.62%	54.88%	49.40%	51.81%	52.20%	53.07%	57.20%	49.67%	49.02%
Operating margin	-5.07%	-2.62%	-9.73%	-4.12%	-7.76%	-0.82%	-2.04%	-2.12%	4.52%	-7.76%	-7.59%
Pretax margin	-6.05%	-3.36%	-10.50%	-4.41%	-0.86%	7.76%	-2.59%	-2.68%	3.83%	-8.22%	-9.43%
Profit margin	-6.05%	-3.36%	-10.50%	-4.41%	-0.86%	7.76%	-2.59%	-2.68%	3.83%	-8.22%	-9.43%
EBITDA margin	-3.69%	-1.38%	-8.44%	-2.94%	-6.28%	0.36%	-0.24%	-0.05%	6.84%	-5.22%	-4.17%
Effective tax rate	—	—	—	—	—	0.00%	—	—	0.00%	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: ECIA (OTC)
Fiscal year ends: March 31
Incorporated in: CO
Headquarters: Boulder, CO
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 930775
Former names: ELECTROSCOPE INC (until Aug 1, 2000)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.